Trial intelligence / Profile preview

Tropisetron for prevention of post-cardiac bypass delirium

ACTRN12606000006549Phase 4Not yet recruiting

Sponsor
Dr Bradley La Ferlita
Start
Jun 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in delirium comparing Tropisetron with Placebo (2 arms). Primary endpoint: Post-cardiopulmonary bypass related delirium. Planned start Jun 2006; status: not yet recruiting.

02

Drugs

tropisetron
03

Conditions

delirium

Beyond the preview

Go deeper on ACTRN12606000006549.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12606000006549.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call